NPI: 1740249655 · WICHITA, KS 67214 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/20/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/20/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 14,459 | $345K |
| 2019 | 8,032 | $104K |
| 2020 | 11,131 | $186K |
| 2021 | 15,832 | $148K |
| 2022 | 9,964 | $164K |
| 2023 | 9,176 | $195K |
| 2024 | 3,854 | $159K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 22,181 | 2,040 | $1.07M |
| 90935 | Hemodialysis procedure with single evaluation by a physician | 3,613 | 258 | $190K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 18,518 | 1,234 | $30K |
| J1756 | Injection, iron sucrose, 1 mg | 4,318 | 1,159 | $3K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 991 | 181 | $3K |
| J1270 | Injection, doxercalciferol, 1 mcg | 7,673 | 786 | $1K |
| 90670 | 29 | 19 | $338.96 | |
| A4657 | Syringe, with or without needle, each | 4,263 | 1,724 | $314.17 |
| 83970 | 1,315 | 1,136 | $297.48 | |
| A9270 | Non-covered item or service | 2,163 | 193 | $155.27 |
| 82728 | 1,029 | 854 | $118.63 | |
| 90674 | 86 | 74 | $114.43 | |
| 83550 | 909 | 737 | $53.49 | |
| 0002A | 13 | 12 | $40.00 | |
| 0001A | 15 | 13 | $40.00 | |
| 83540 | 1,057 | 877 | $31.29 | |
| 85041 | 1,625 | 1,378 | $24.91 | |
| 85048 | 1,622 | 1,373 | $22.33 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 420 | 230 | $18.98 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 160 | 73 | $9.53 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 177 | 149 | $9.35 |
| 82108 | 97 | 81 | $0.45 | |
| G0008 | Administration of influenza virus vaccine | 133 | 111 | $0.06 |
| G0009 | Administration of pneumococcal vaccine | 28 | 20 | $0.03 |
| 82607 | 13 | 12 | $0.00 |